EOX group (n = 102) | US group (n = 102) | P | |
---|---|---|---|
Clavien–Dindo grade, n (%)a | 0.877 | ||
0 | 12 (11.8) | 13 (12.7) | |
1 | 24 (23.5) | 31 (30.4) | |
2 | 40 (39.2) | 41 (40.2) | |
3a | 17 (16.7) | 11 (10.8) | |
3b | 2 (2.0) | 2 (2.0) | |
4a | 3 (2.9) | 2 (2.0) | |
4b | 2 (2.0) | 1 (1.0) | |
5 | 1 (1.0) | 2 (2.0) | |
CCI, median (IQR) | 22.6 (8.7–30.8) | 22.6 (8.7–34.2) | 0.959 |
Reoperation, n (%) | 5 (4.9) | 4 (3.9) | 1.000 |
ICU admission, n (%) | 17 (16.7) | 7 (6.9) | 0.030 |
ICU stay (days), median (IQR)b | 3.0 (2.0–7.0) | 3.0 (2.0–8.0) | 0.871 |
Length of hospital stay (days), median (IQR) | 8.0 (7.0–11.0) | 9.0 (7.0–12.0) | 0.258 |
Readmission, n (%) | 11 (10.8) | 9 (8.8) | 0.638 |
30-day mortality, n (%) | 1 (1.0) | 2 (2.0) | 1.000 |
90-day mortality, n (%) | 1 (1.0) | 3 (2.9) | 0.621 |